Schaper Benz & Wise Investment Counsel Inc decreased Waters Corp. (WAT) stake by 3.82% reported in 2018Q1 SEC filing. Schaper Benz & Wise Investment Counsel Inc sold 4,775 shares as Waters Corp. (WAT)’s stock declined 8.54%. The Schaper Benz & Wise Investment Counsel Inc holds 120,091 shares with $23.86 million value, down from 124,866 last quarter. Waters Corp. now has $15.19 billion valuation. The stock decreased 0.60% or $1.17 during the last trading session, reaching $193.85. About 141,839 shares traded. Waters Corporation (NYSE:WAT) has risen 6.75% since June 20, 2017 and is uptrending. It has underperformed by 5.82% the S&P500. Some Historical WAT News: ; 29/05/2018 – Waters DART QDa System with LivelD Software lnstantly Assesses Food Quality and Authenticity; 27/03/2018 – GERMANY GRANTS NORD STREAM 2 BUILDING APPROVAL IN HOME WATERS; 24/04/2018 – Waters Corp Sees FY18 EPS $8.10-EPS $8.30; 17/05/2018 – RUSSIA’S ROSNEFT ROSN.MM SAYS ITS SOUTH CHINA SEA DRILLING IS WITHIN VIETNAM WATERS, IN ACCORDANCE WITH VIETNAM LEGISLATION; 16/04/2018 – Hometown Source: Boundary Waters: A way to disconnect from the world; 06/03/2018 – FinSrvcsMinority: At Markup of Budget Views, Waters Blasts Harmful Republican Agenda; 19/04/2018 – Rep. Waters: CONGRESSWOMAN MAXINE WATERS NAMED TO TIME’S 100 MOST INFLUENTIAL PEOPLE OF 2018; 10/04/2018 – Waters Presenting at Deutsche Bank Health Care Conference May 8; 24/04/2018 – WATERS CORP – FOREIGN CURRENCY TRANSLATION INCREASED YEAR-OVER-YEAR SALES GROWTH BY APPROXIMATELY 5% FOR QUARTER; 18/05/2018 – U.S. District Court for the District of Connecticut Grants Nestlé Waters North America’s Motion to Dismiss Poland Spring Lawsuit
VIFOR PHARMA AG COMMON SHARES (OTCMKTS:GNHAF) had a decrease of 6.77% in short interest. GNHAF’s SI was 1.06 million shares in June as released by FINRA. Its down 6.77% from 1.14 million shares previously. It closed at $137 lastly. It is up 0.00% since June 20, 2017 and is . It has underperformed by 12.57% the S&P500.
Vifor Pharma AG develops, manufactures, and distributes pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company has market cap of $. The firm operates in three divisions: Vifor Pharma, Health & Beauty, and Services. It currently has negative earnings. It offers iron replacement products, including Ferinject/Injectafer, Venofer, Maltofer, and Velphoro; immuno-stimulant products, such as Broncho-Vaxom and Uro-Vaxom; and synthetic and biotech drugs for use in immunology, as well as for the treatment of infectious diseases.
Another recent and important Waters Corporation (NYSE:WAT) news was published by Seekingalpha.com which published an article titled: “Buy These Waters” on June 07, 2018.
Analysts await Waters Corporation (NYSE:WAT) to report earnings on July, 24. They expect $1.92 earnings per share, up 9.09% or $0.16 from last year’s $1.76 per share. WAT’s profit will be $150.42M for 25.24 P/E if the $1.92 EPS becomes a reality. After $1.59 actual earnings per share reported by Waters Corporation for the previous quarter, Wall Street now forecasts 20.75% EPS growth.
Since January 25, 2018, it had 0 insider purchases, and 12 selling transactions for $27.64 million activity. KUEBLER CHRISTOPHER A sold $86,944 worth of stock or 416 shares. $278,826 worth of Waters Corporation (NYSE:WAT) was sold by Kelly Terrence P. $3.13 million worth of Waters Corporation (NYSE:WAT) was sold by Harrington Michael C. Shares for $1.08 million were sold by BEAUDOUIN MARK T. Another trade for 28,400 shares valued at $6.22M was made by Rae Elizabeth B on Monday, January 29. 3,521 Waters Corporation (NYSE:WAT) shares with value of $671,716 were sold by SILVEIRA MICHAEL F. 1,523 shares valued at $318,002 were sold by TERRICCIANO DAVID on Wednesday, February 28.
Investors sentiment decreased to 0.9 in Q1 2018. Its down 0.23, from 1.13 in 2017Q4. It dived, as 29 investors sold WAT shares while 185 reduced holdings. 51 funds opened positions while 142 raised stakes. 70.29 million shares or 2.51% less from 72.10 million shares in 2017Q4 were reported. Clearbridge Invs Ltd Limited Liability Company stated it has 4,251 shares. Raymond James And Assocs holds 0.03% or 80,964 shares. Moreover, Bailard has 0.07% invested in Waters Corporation (NYSE:WAT) for 5,348 shares. Lombard Odier Asset Management (Switzerland) owns 0.21% invested in Waters Corporation (NYSE:WAT) for 10,231 shares. Sei Com has 0.04% invested in Waters Corporation (NYSE:WAT). State Common Retirement Fund, a New York-based fund reported 301,806 shares. State Teachers Retirement Sys invested in 0.06% or 121,481 shares. Smithfield Co stated it has 0% of its portfolio in Waters Corporation (NYSE:WAT). S&Co stated it has 9,210 shares or 0.23% of all its holdings. Compton Mngmt Inc Ri holds 9,418 shares or 0.78% of its portfolio. Wetherby Asset Mgmt holds 0.07% or 2,642 shares. Caledonia Investments Public Limited Liability Company holds 90,000 shares. Commonwealth Of Pennsylvania School Empls Retrmt Sys stated it has 0.02% of its portfolio in Waters Corporation (NYSE:WAT). Parkside Natl Bank Trust owns 21 shares. Sg Americas Lc reported 0.03% of its portfolio in Waters Corporation (NYSE:WAT).
Schaper Benz & Wise Investment Counsel Inc increased General Electric (NYSE:GE) stake by 85,380 shares to 365,238 valued at $4.92M in 2018Q1. It also upped Kimberly (NYSE:KMB) stake by 5,945 shares and now owns 161,797 shares. Enbridge (NYSE:ENB) was raised too.